60 Degrees Pharmaceuticals Soars After Runway Health Partnership

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares are trading higher Thursday after the company announced a partnership with Runway Health to expand pre-departure access to ARAKODA.

60 Degrees Partners With Runway Health on ARAKODA Access

The company said the partnership adds a travel-focused consumer telehealth platform to its ARAKODA marketing strategy, allowing international travelers to access physician-led online consultations through Runway Health before traveling to malaria-endemic regions. If prescribed, medication is delivered directly to patients ahead of departure.

ARAKODA is the only FDA-approved, broad-spectrum, once-weekly prescription option for malaria prevention available to international travelers in the U.S., according to the company.

60 Degrees Pharmaceuticals said the partnership with Runway Health is set to commence April 2. The collaboration enables eligible users to align their travel itineraries with personalized treatment plans developed by U.S.-licensed healthcare providers through Runway Health's platform.

SXTP Price Action: At the time of writing, 60 Degrees shares are trading 179.50% higher at $5.61, according to data from Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.